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Background
Alzheimer’s disease (AD) is characterized by extracellular
deposits of b-amyloid (Ab), intracellular neurofibrillary
tangles and inflammation response. The a7 nicotinic
receptors (nAChRs) were proposed to be directly relevant
to the pathogenesis of AD by interacting with Ab. The a7
nAChRs and Ab1-42 are co-localized in neuritic plaques
and neurons and can form a high affinity stable complex.
The up-regulation of a7 nAChRs on activated astrocytes
has been reported in the AD brain. However, because of
the poor specificity of currently available a7 nAChR anti-
bodies, it is important to develop new ways to investigate
the discrete distribution of a7 nAChRs in nervous tissue.
Material and methods
a7 nAChR single immunocytochemistry, double and tri-
ple-labeling immunocytochemistry were performed on
formalin-fixed paraffin-embedded sections from 8 brain
samples of neuropathologically confirmed sporadic AD
and age-matched controls. Tissues were obtained from the
Quebec Brain Bank (QBB; Douglas Institute, Montréal,
QC, Canada). Immunohistochemical staining was per-
formed as described previously (Yu et al., 2005). Primary
cortical and hippocampal astrocytic cultures were pre-
pared from the brains of newborn mouse (129S6 strain)
according to the procedure of McCarthy and de Vellis
(1980). The purified astrocytes were exposed to 100 nM
Ab1–42 oligomers for 24h at 37 C with or without co-treat-
ment with a series of concentration of PNU282987 and
S24795 for 12 h. To inhibit a7 nAChR activities, cells
were pretreated with methyllycaconitine (MLA) for 45
min before Ab1–42 oligomers/PNU282987/S24795. After
Ab1–42 treatments for 24 hours, the culture media were
collected and was concentrated using Centricon YM-3
(Millipore, Temecula, CA). To prepare cell lysates, the
treated cells were rinsed with 1× PBS, quick frozen then
lysed on ice for 30 min in a lysis buffer. The lysates were
then centrifuged at 10,000 × g for 15 min, and the super-
natant was collected. Protein concentrations were deter-
mined and equalized before samples were applied to
western blotting for measuring Ab oligomers.
Results
We successfully characterized the distribution of a7
nAChRs in AD brains using biotin conjugated a-bungaro-
toxin. Our morphological data show the upregulation of
a7 nAChRs in activated astrocytes in the AD brain. A cer-
tain proportion of a7 nAChRs positive astrocyes were
morphologically associated with amyloid plaques. In mouse
primary cultured astrocytes, treatments with different a7
nAChR agonists (PNU282987, S24795) significantly
enhanced astrocytic Ab phagocytosis and inhibited Ab1-42
aggregation.
Conclusion
Take together, our study suggest that astrocytic a7
nAChRs possibly contribute to the initiation and develop-
ment of amyloid pathology in the AD brain and thus
should be considered as a potential therapeutic target, in
addition to the better characterized neuronal nicotinic
receptors.
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